After testicular cancer, lifelong surveillance is crucial. Once your treatment is complete, your doctor will likely recommend that you perform self-exams and return for regular checkups.

During these checkups, your doctor will examine the unaffected testicle for any lumps or abnormalities and possibly recommend periodic blood tests to look for tumor markers and order regular chest x-rays or CT scans to detect any tumors.

As part of your follow-up care, you will be seen by an advanced practice provider (APP). APPs are members of your healthcare team that work with your doctor to provide you with care or may see you instead of your doctor. APPs have specialized training. One type of APP is a nurse practitioner (NP).

One of our nurse practitioners will provide additional follow-up care for you. This NP specializes in caring for people who have had testicular cancer and knows how to monitor your health for any signs that cancer has come back. The NP can also help you manage any side effects you may have from being treated for cancer.

A visit with your NP includes:

• a review of your recent medical history and a physical examination
• screening referrals for other cancers
• healthy lifestyle recommendations, including nutrition, exercise, and help quitting smoking
• a treatment summary and follow-up care plan

After each visit, the NP will give a treatment summary and survivorship plan of care to you and your healthcare providers. Your treatment team can incorporate this information into your overall medical plan.

Your full treatment history with MSK is always available to your primary care doctors.

Your MSK Follow-Up Providers

Rehabilitation and Exercise

Cancer treatment can sap your strength, flexibility, mobility, and endurance. Our rehabilitation specialists can teach you therapeutic exercises and training programs that can help you heal. Our state-of-the-art facilities are specially tailored to the needs of people who’ve undergone treatment for cancer.

Learn more about how we can help you get moving again.